Prominent Chinese Scientist Failed to Disclose Company Ties in COVID-19 Clinical Trial Paper Prominent Chinese Scientist Failed to Disclose Company Ties in COVID-19 Clinical Trial Paper

Last May, Nanshan Zhong published results from a clinical trial that tested whether a traditional Chinese medicine could be used to treat COVID-19 patients.Retraction Watch
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news